Literature DB >> 8901739

Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model.

T Shinoka1, P X Ma, D Shum-Tim, C K Breuer, R A Cusick, G Zund, R Langer, J P Vacanti, J E Mayer.   

Abstract

BACKGROUND: We have previously reported the successful creation of tissue-engineered valve leaflets and the implantation of these autologous tissue leaflets in the pulmonary valve position. This study was designed to trace cultured cells that were seeded onto a biodegradable polymer with the use of a 1,1'-dioctadecyl-3,3,3' 3'-tetramethylindo-carbocyanine perchlorate (Di-1) cell-labeling method. We also examined the time-related biochemical, biomechanical, and histological characteristics and evolution of these tissue constructs. METHODS AND
RESULTS: Mixed cell populations of endothelial cells and fibroblasts were isolated from explanted ovine arteries. Endothelial cells were selectively labeled with an acetylated low density lipoprotein marker and separated from fibroblasts with the use of a fluorescence-activated cell sorter. A synthetic biodegradable scaffold consisting of polyglycolic acid fibers was seeded first with fibroblasts, then coated with endothelial cells. Using these methods, we implanted autologous cell/polymer constructs in six animals. In two additional control animals, a leaflet of polymer was implanted without prior cell seeding. In each animal, cardiopulmonary bypass was used to completely resect the right posterior leaflet of the pulmonary valve and replace it with an engineered valve leaflet with (n = 6) or without (n = 2) prior cultured cell seeding. The animals were killed either after 6 hours or after 1, 6, 7, 9, or 11 weeks, and the implanted valve leaflets were examined histologically, biochemically, and biomechanically. 4-Hydroxyproline assays were performed to determine collagen content. Leaflet strength was evaluated in vitro with a mechanical tester Factor VIII and elastin stains were done to verify histologically that endothelial cells and elastin, respectively, were present. Animals receiving leaflets made from polymers without cell seeding were killed and examined in a similar fashion after 8 weeks. In the control animals, the acellular polymer leaflets were completely degraded, with no residual leaflet tissue at 8 weeks. The tissue-engineered valve leaflet persisted in each animal in the experimental group. 4-Hydroxyproline analysis of the constructs showed a progressive increase in collagen content. Immunohistochemical staining demonstrated elastin fibers in the matrix and factor VIII on the surface of the leaflet. The cell-labeling experiments demonstrated that the cells on the leaflets had persisted from the in vitro seeding of the leaflets.
CONCLUSIONS: In the tissue-engineered heart valve leaflet, transplanted autologous cells generated a proper matrix on the polymer scaffold in a physiological environment at a period of 8 weeks after implantation.

Entities:  

Mesh:

Year:  1996        PMID: 8901739

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  30 in total

1.  Metal mesh scaffold for tissue engineering of membranes.

Authors:  S Hamed Alavi; Arash Kheradvar
Journal:  Tissue Eng Part C Methods       Date:  2011-12-22       Impact factor: 3.056

Review 2.  Heart valve and arterial tissue engineering.

Authors:  C E Sarraf; A B Harris; A D McCulloch; M Eastwood
Journal:  Cell Prolif       Date:  2003-10       Impact factor: 6.831

Review 3.  Tissue engineering and regenerative medicine research perspectives for pediatric surgery.

Authors:  Amulya K Saxena
Journal:  Pediatr Surg Int       Date:  2010-03-24       Impact factor: 1.827

Review 4.  Getting to the heart of tissue engineering.

Authors:  Luda Khait; Louise Hecker; Nicole R Blan; Garrett Coyan; Francesco Migneco; Yen-Chih Huang; Ravi K Birla
Journal:  J Cardiovasc Transl Res       Date:  2008-01-29       Impact factor: 4.132

Review 5.  Umbilical cord cells as a source of cardiovascular tissue engineering.

Authors:  Christian Breymann; Dörthe Schmidt; S P Hoerstrup
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 6.  Tissue engineering of heart valves using decellularized xenogeneic or polymeric starter matrices.

Authors:  Dörthe Schmidt; Ulrich A Stock; Simon P Hoerstrup
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-08-29       Impact factor: 6.237

Review 7.  Tissue engineering on matrix: future of autologous tissue replacement.

Authors:  Benedikt Weber; Maximilian Y Emmert; Roman Schoenauer; Chad Brokopp; Laura Baumgartner; Simon P Hoerstrup
Journal:  Semin Immunopathol       Date:  2011-01-29       Impact factor: 9.623

Review 8.  Heart Valve Replacements with Regenerative Capacity.

Authors:  Petra E Dijkman; Emanuela S Fioretta; Laura Frese; Francesco S Pasqualini; Simon P Hoerstrup
Journal:  Transfus Med Hemother       Date:  2016-07-26       Impact factor: 3.747

9.  Polymer scaffolds for small-diameter vascular tissue engineering.

Authors:  Haiyun Ma; Jiang Hu; Peter X Ma
Journal:  Adv Funct Mater       Date:  2010-09-09       Impact factor: 18.808

10.  In vivo evaluation of an in-body, tissue-engineered, completely autologous valved conduit (biovalve type VI) as an aortic valve in a goat model.

Authors:  Yoshiaki Takewa; Masashi Yamanami; Yuichiro Kishimoto; Mamoru Arakawa; Keiichi Kanda; Yuichi Matsui; Tomonori Oie; Hatsue Ishibashi-Ueda; Tsutomu Tajikawa; Kenkichi Ohba; Hitoshi Yaku; Yoshiyuki Taenaka; Eisuke Tatsumi; Yasuhide Nakayama
Journal:  J Artif Organs       Date:  2012-12-20       Impact factor: 1.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.